Berlin, Germany

Jiang Gao


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jiang Gao - Innovator in Catalytic Nucleic Acids

Introduction

Jiang Gao is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of active substance release systems through his innovative research and patents. His work focuses on the development of temperature-dependent activation of catalytic nucleic acids, which has potential applications in various therapeutic areas.

Latest Patents

Jiang Gao holds a patent titled "Temperature dependent activation of catalytic nucleic acids for controlled active substance release." This invention relates to an active substance release system that comprises two compounds. The first compound includes a nanoparticle combined with an oligonucleotide inhibition strand that is hybridized with a catalytically active nucleic acid. The second compound consists of a carrier combined with a substrate molecule that is coupled to a therapeutic active substance. Through external stimulation, the catalytically active nucleic acid of the first compound is released and specifically binds to the substrate molecule of the second compound. This interaction leads to the cleavage of the substrate molecule, resulting in the release of the active substance bound to it.

Career Highlights

Jiang Gao is associated with Magforce AG, where he continues to advance his research and development efforts. His work has garnered attention for its innovative approach to drug delivery systems, which could revolutionize how therapeutic agents are administered.

Collaborations

Jiang collaborates with notable colleagues, including Monika Fischler and Volker A Erdmann. Their combined expertise contributes to the success of their projects and enhances the research environment at Magforce AG.

Conclusion

Jiang Gao is a key figure in the field of catalytic nucleic acids, with a focus on developing advanced systems for controlled active substance release. His innovative patent and collaborative efforts position him as a significant contributor to the future of therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…